Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
Synexus is partnering with the University of Exeter to launch a registry-based study in the U.S. to better understand how healthy brains age.
Novotech has inked a partnership deal with the Asian Eye Institute for clinical research with the ophthalmology firm.
BMJ authors are calling for more coordination between regulatory agencies in the Americas to improve health data transparency in clinical trials.
U.K.-based CRO Clinigen has bought the rights to Novartis’ Proleukin (aldesleukin) outside the U.S. as it looks to boost sales.
Synteract snapped up specialty contract researcher Cu-Tech, with plans to establish a dedicated center for dermatology development.
Cel-Sci won a yearslong arbitration battle with inVentiv, now known as Syneos Health, over breach of contract and missed phase 3 enrollment promises.
Pluristem and Thermo Fisher will collaborate to scale up manufacturing of regenerative medicines, to build an industry capable of millions of doses.
The German dermatology CRO Proinnovera has opened a new U.S. base of operations through a wholly owned subsidiary based in Wilmington, North Carolina.
Precision Therapeutics and Helomics have agreed to cement their close ties, aiming to share AI, diagnostics and CRO offerings.
AstraZeneca, Cambridge University and Lumicks formed a discovery hub focused on visualizing the molecules behind disease pathways and treatments.